United-Guardian Q2 FY26 net income climbs 16% to $728,579; net sales rise 10% to $3.11 million
UG•Sales mix and outlook
Cosmetic ingredient sales rose 44% in the second quarter and 34% in the first half, driven by higher purchases from Ashland Specialty Ingredients.
Pharmaceutical sales increased 1% in the second quarter and 11% in the first half, led by Renacidin. The company highlighted expanded promotion plans for Renacidin and “natural” products.
First-half performance
For the first half, net sales climbed 12% to $5.98 million and net income jumped 30% to $1.55 million.
Second-quarter results
United-Guardian posted second-quarter net sales up 10% to $3.11 million and net income rose 16% to $728,579.
Diluted earnings per share increased to $0.16 from $0.14.




